| Financial Year |
March 31 2023 |
| Monetary Funds |
1,817,909,727.89 |
| Held-for-trading Financial Assets |
301,176,481.75 |
| Notes Receivable |
-- |
| Accounts Receivable |
288,178,357.68 |
| Advances to Suppliers |
76,413,554.54 |
| Other Receivables |
31,954,424.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,660,829,249.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
156,809,775.70 |
| Total Current Assets |
4,632,707,135.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
79,007,737.97 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,863,736,193.49 |
| Under-construction Projects |
64,151,913.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
101,806,271.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
77,233,997.18 |
| Deferred Income Tax Assets |
65,643,583.24 |
| Other Non-Current Assets |
33,239,794.56 |
| Sub-Total of Non-Current Assets |
2,866,806,532.75 |
| Total Assets |
7,499,513,668.61 |
| Short-Term Loans |
1,067,957,742.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,226,000.00 |
| Accounts Payable |
600,253,417.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,385,314.92 |
| Taxes Payable |
147,798,411.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,541,072.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
200,177,222.23 |
| Other Current Liabilities |
3,443,642.16 |
| Sub-Total of Current Liabilities |
2,104,275,913.21 |
| Long-term Loans |
46,047,788.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
284,277,100.98 |
| Other Non-Current Liabilities |
9,065,426.44 |
| Sub-Total of Non-Current Liabilities |
351,060,859.87 |
| Total Liabilities |
2,455,336,773.08 |
| Paid-In Capital(Or Share Stock) |
309,617,139.00 |
| Capital Surplus |
2,580,426,290.93 |
| Surplus Reserve |
70,885,074.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,965,236,478.98 |
| Minority Stockholder's Interest |
11,503.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,044,165,391.56 |
| Owner's Equity（Stockholder's Equity） |
5,044,176,895.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,499,513,668.61 |
